Recherche (Nouvelles)

Wave Life Sciences Announces Positive Interim Phase 1 Data From INLIGHT: Further Improvements In Body Composition, With Clinically Meaningful Reductions In Visceral Fat And Waist Circumference, At Six Months Following Single Dose Of WVE-007

top health

(MENAFN - GlobeNewsWire - Nasdaq) At 6-month follow-up, a single 240 mg dose of WVE-007 (INHBE GalNAc-siRNA) continued to drive significant placebo-adjusted reductions in visceral fat (-14%; p ...
2026-03-26 07:31:36